Sanofi (SNY)
(Delayed Data from NSDQ)
$57.63 USD
-0.63 (-1.08%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $57.64 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Sanofi falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 9,427 | 13,419 | 11,947 | 15,895 | 10,558 |
Receivables | 9,550 | 9,270 | 9,678 | 8,557 | 8,889 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 10,462 | 9,440 | 10,311 | 9,540 | 8,953 |
Other Current Assets | 3,756 | 3,721 | 4,225 | 4,506 | 3,643 |
Total Current Assets | 33,194 | 35,850 | 36,160 | 38,499 | 32,044 |
Net Property & Equipment | 10,996 | 10,398 | 11,864 | 10,698 | 10,883 |
Investments & Advances | 459 | 713 | 296 | 230 | 4,022 |
Other Non-Current Assets | 0 | 90 | 105 | 95 | 364 |
Deferred Charges | 6,956 | 5,669 | 5,440 | 4,811 | 6,086 |
Intangibles | 79,790 | 75,366 | 82,182 | 71,719 | 68,422 |
Deposits & Other Assets | 3,686 | 3,516 | 3,907 | 3,406 | 2,987 |
Total Assets | 136,872 | 133,514 | 142,258 | 130,827 | 126,264 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7,931 | 7,178 | 7,312 | 6,048 | 5,951 |
Current Portion Long-Term Debt | 2,213 | 4,398 | 3,766 | 3,161 | 5,100 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 646 | 605 | 366 | 690 | 0 |
Other Current Liabilities | 15,097 | 12,776 | 13,433 | 11,823 | 11,483 |
Total Current Liabilities | 26,185 | 25,248 | 25,194 | 21,987 | 22,827 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2,010 | 1,940 | 1,913 | 2,022 | 2,569 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 15,528 | 15,653 | 20,258 | 22,555 | 22,547 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 10,778 | 9,487 | 11,047 | 11,067 | 11,015 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 56,400 | 54,334 | 60,588 | 58,694 | 60,063 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2,738 | 2,657 | 2,990 | 2,876 | 2,809 |
Capital Surplus | 339 | 132 | 629 | 414 | 165 |
Retained Earnings | 73,054 | 70,311 | 74,551 | 68,591 | 57,994 |
Other Equity | 5,623 | 6,824 | 4,612 | 1,058 | 5,244 |
Treasury Stock | 1,281 | 744 | 1,111 | 805 | 10 |
Total Shareholder's Equity | 80,472 | 79,180 | 81,671 | 72,133 | 66,201 |
Total Liabilities & Shareholder's Equity | 136,872 | 133,514 | 142,258 | 130,827 | 126,264 |
Total Common Equity | 80,472 | 79,180 | 81,671 | 72,133 | 66,201 |
Shares Outstanding | 2,529.50 | 2,521.60 | 2,521.50 | 2,504.10 | 2,504.10 |
Book Value Per Share | 31.81 | 31.40 | 32.39 | 28.81 | 26.44 |
Fiscal Year End for Sanofi falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7,318 | 0 | 9,427 | 0 | 8,716 |
Receivables | 9,482 | 0 | 9,550 | 0 | 9,423 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11,425 | 0 | 10,462 | 0 | 10,871 |
Other Current Assets | 4,168 | 0 | 3,756 | 0 | 3,676 |
Total Current Assets | 32,392 | 0 | 33,194 | 0 | 32,686 |
Net Property & Equipment | 11,053 | 0 | 10,996 | 0 | 10,690 |
Investments & Advances | 339 | 0 | 459 | 0 | 587 |
Other Non-Current Assets | 2 | 0 | 0 | 0 | 291 |
Deferred Charges | 7,844 | 0 | 6,956 | 0 | 6,521 |
Intangibles | 82,634 | 0 | 79,790 | 0 | 80,508 |
Deposits & Other Assets | 3,728 | 0 | 3,686 | 0 | 3,524 |
Total Assets | 139,733 | 0 | 136,872 | 0 | 136,685 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 8,005 | 0 | 7,931 | 0 | 8,031 |
Current Portion Long-Term Debt | 9,946 | 0 | 2,213 | 0 | 5,118 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 142 | 0 | 646 | 0 | 411 |
Other Current Liabilities | 13,943 | 0 | 15,097 | 0 | 13,162 |
Total Current Liabilities | 32,336 | 0 | 26,185 | 0 | 26,998 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,938 | 0 | 2,010 | 0 | 2,126 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 13,464 | 0 | 15,528 | 0 | 15,528 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 11,517 | 10,778 | 0 | 10,485 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 61,123 | 0 | 56,400 | 0 | 57,144 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2,728 | 0 | 2,738 | 0 | 2,753 |
Capital Surplus | 341 | 0 | 339 | 0 | 153 |
Retained Earnings | 70,099 | 0 | 73,054 | 0 | 71,633 |
Other Equity | 6,919 | 0 | 5,623 | 0 | 6,046 |
Treasury Stock | 1,476 | 0 | 1,281 | 0 | 1,044 |
Total Shareholder's Equity | 78,610 | 0 | 80,472 | 0 | 79,541 |
Total Liabilities & Shareholder's Equity | 139,733 | 0 | 136,872 | 0 | 136,685 |
Total Common Equity | 78,610 | 0 | 80,472 | 0 | 79,541 |
Shares Outstanding | 2,532.70 | 2,529.70 | 2,529.50 | 2,529.50 | 2,524.70 |
Book Value Per Share | 31.04 | 0.00 | 31.81 | 0.00 | 31.51 |